We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$629B
AUM Growth
+$13B
Cap. Flow
+$935M
Cap. Flow %
0.15%
Top 10 Hldgs %
19.19%
Holding
2,649
New
91
Increased
1,526
Reduced
842
Closed
97

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$2.29B
2
META icon
Meta Platforms (Facebook)
META
+$1.81B
3
AVGO icon
Broadcom
AVGO
+$1.61B
4
TSLA icon
Tesla
TSLA
+$1.59B
5
SRE icon
Sempra
SRE
+$1.26B

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.14B
2
AMZN icon
Amazon
AMZN
+$2.54B
3
AET
Aetna Inc
AET
+$1.44B
4
BIIB icon
Biogen
BIIB
+$1.4B
5
NFLX icon
Netflix
NFLX
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 16.14%
3 Financials 15.97%
4 Consumer Discretionary 14.71%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSTM icon
2176
HealthStream
HSTM
$849M
$388K ﹤0.01%
15,613
+50
+0.3% +$1.2K
TEVA icon
2177
PUT
Teva Pharmaceuticals
TEVA
$42.6B
$388K ﹤0.01%
+22,700
New +$443K
CALA
2178
DELISTED
Calithera Biosciences, Inc
CALA
$387K ﹤0.01%
3,072
+643
+26% +$100K
BANC icon
2179
Banc of California
BANC
$3.11B
$386K ﹤0.01%
20,007
+85
+0.4% +$1.73K
SNEX icon
2180
StoneX
SNEX
$8.05B
$386K ﹤0.01%
45,750
+152
+0.3% +$1.28K
KNL
2181
DELISTED
Knoll, Inc.
KNL
$384K ﹤0.01%
19,028
+94
+0.5% +$2.08K
CAC icon
2182
Camden National
CAC
$996M
$383K ﹤0.01%
8,615
+30
+0.3% +$1.3K
FARM
2183
DELISTED
Farmer Brothers
FARM
$382K ﹤0.01%
12,660
+17
+0.1% +$535
DOOR
2184
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$381K ﹤0.01%
6,211
+105
+2% +$7.07K
REIS
2185
DELISTED
Reis, Inc.
REIS
$381K ﹤0.01%
17,743
+18
+0.1% +$365
AROW icon
2186
Arrow Financial
AROW
$723M
$379K ﹤0.01%
13,340
-4,988
-27% -$140K
ANCX
2187
DELISTED
Access National Corp
ANCX
$379K ﹤0.01%
13,268
+3,629
+38% +$105K
PLNT icon
2188
Planet Fitness
PLNT
$3.71B
$378K ﹤0.01%
9,996
+169
+2% +$5.92K
XOG
2189
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$377K ﹤0.01%
32,891
+7,311
+29% +$97.1K
DNOW icon
2190
DNOW Inc
DNOW
$2.95B
$376K ﹤0.01%
36,791
+358
+1% +$3.9K
IEFA icon
2191
iShares Core MSCI EAFE ETF
IEFA
$196B
$374K ﹤0.01%
+5,679
New +$382K
SCS
2192
DELISTED
Steelcase
SCS
$371K ﹤0.01%
27,278
+314
+1% +$4.6K
TRI icon
2193
Thomson Reuters
TRI
$46B
$371K ﹤0.01%
8,272
PRGX
2194
DELISTED
PRGX Global, Inc.
PRGX
$370K ﹤0.01%
39,200
CSII
2195
DELISTED
Cardiovascular Systems, Inc.
CSII
$369K ﹤0.01%
16,843
+65
+0.4% +$1.56K
GLUU
2196
DELISTED
Glu Mobile Inc.
GLUU
$369K ﹤0.01%
97,906
+85,006
+659% +$319K
ESGR
2197
DELISTED
Enstar Group
ESGR
$368K ﹤0.01%
1,751
-247,271
-99% -$51M
GERN icon
2198
Geron
GERN
$982M
$365K ﹤0.01%
85,890
+66,690
+347% +$180K
XXII
2199
22nd Century Group
XXII
$1.42M
0
DNR
2200
DELISTED
Denbury Resources, Inc.
DNR
$365K ﹤0.01%
133,046
-137,525
-51% -$324K

Similar funds

T. Rowe Price Associates's Q1 2018 Portfolio in Review

As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
  • T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
  • T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
  • T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
  • T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
  • T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.